Open Access Open Access  Restricted Access Subscription Access

Drugs Acting on Arrhythmics

Muralinath E., Pooja Devi, Prasanta Chbukdhara, Sanjib Borah, Kalyan C., Archana Jain, Guruprasad M.

Abstract


ABSTRACT

Antiarrhythmic drugs play a key role regarding abnormal heart rhythms. Anti-arrhythmic drugs are divided into different classes dependent on their primary mechanism of action. These drugs are regarded as into four main categories such as class I (sodium channel blockers), class II(beta _ blockers), class III (potassium channel blockers) and class IV (calcium channel blockers). Class I anti arrhythmics specifically act on sodium channels, which play a role in the initiation and conduction of action potentials particularly in Cardiac cells. Class II anti arrhythmics act by decreasing the effects of adrenaline on the heart. Class III antiarrhythmics affect potassium channels and carry on the repolarization phase of the Cardiac action potential. Potential class IV antiarthmics stop calcium influx during depolarization and result in acdecrement in the heart rate and the forcec of contraction. Finally it is concluded that anti arrhythmic drugs play a critical role in managing various vtyoes of arrhythmias.


Full Text:

PDF

References


Lakshminarayan, K., Anderson, D. C., Herzog, C. A., & Qureshi, A. I. (2008). Clinical epidemiology of atrial fibrillation and related cerebrovascular events in the United States. The neurologist, 14(3), 143.

Hafeez, Y., Rodriguez, B. S. Q., Ahmed, I., Grossman, S. A., & Haddad, L. M. (2023). Paroxysmal Supraventricular Tachycardia (Nursing). In StatPearls [Internet]. StatPearls Publishing.

Hafeez, Y., Rodriguez, B. S. Q., Ahmed, I., Grossman, S. A., & Haddad, L. M. (2023). Paroxysmal Supraventricular Tachycardia (Nursing). In StatPearls [Internet]. StatPearls Publishing.

Heeringa, J., van der Kuip, D. A., Hofman, A., Kors, J. A., van Herpen, G., Stricker, B. H. C., ... & Witteman, J. C. (2006). Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study. European heart journal, 27(8), 949-953.

Schmidt, C., Kisselbach, J., Schweizer, P. A., Katus, H. A., & Thomas, D. (2011). The pathology and treatment of cardiac arrhythmias: focus on atrial fibrillation. Vascular health and risk management, 193-202.

Ziccardi, M. R., Goyal, A., & Maani, C. V. (2022). Atrial Flutter. StatPearls [Internet].

Cundiff, N. M., Robinson, J. A., Cannon, B. C., & Snyder, C. S. (2018). Atrioventricular junctional tachycardia with exit block in an adolescent. HeartRhythm Case Reports, 4(12), 594-597.

Allen, S. M., Abrich, V. A., Bibby, P. S., Fishman, D., Shen, W. K., & Sorajja, D. (2018). Prevalence and prognostic significance of nonsustained ventricular tachycardia in patients with a left ventricular ejection fraction from 35% to 50%. The American Journal of Cardiology, 121(3), 330-335.9.

Kerola, T., Eranti, A., Aro, A. L., Haukilahti, M. A., Holkeri, A., Junttila, M. J., ... & Marcus, G. M. (2019). Risk factors associated with atrioventricular block. JAMA Network Open, 2(5), e194176-e194176.

Leonelli, F. M., De Ponti, R., & Bagliani, G. (2019). Challenges in Bradicardias Interpretation. Cardiac Electrophysiology Clinics, 11(2), 261-281.


Refbacks

  • There are currently no refbacks.